Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Autor: Lau, David C W a, *, Erichsen, Lars b, Francisco, Ann Marie b, Satylganova, Altynai b, le Roux, Carel W c, McGowan, Barbara d, Pedersen, Sue D e, Pietiläinen, Kirsi H f, g, Rubino, Domenica h, Batterham, Rachel L i, j
Zdroj: In The Lancet 11-17 December 2021 398(10317):2160-2172
Databáze: ScienceDirect